Why the Certificate of Analysis Is Your First Quality Gate
Every research-grade peptide shipment should arrive with a Certificate of Analysis (COA). This document is the supplier's formal declaration that a specific batch has been tested against defined analytical criteria before release. For laboratory researchers, reading the COA critically—rather than filing it unread—is one of the simplest ways to catch potential sources of experimental variability before they corrupt downstream data.
A COA is not marketing material. It is a batch-specific record that reflects real instrument output from real analytical runs. Understanding each field allows you to assess fitness-for-purpose, compare batches, and troubleshoot unexpected results with far greater efficiency.
Batch and Lot Information
The first section of any COA identifies the material itself. Key fields to verify include:
- Product name and catalog number: Confirm these match your purchase order exactly. Sequence errors at the ordering stage are more common than researchers expect.
- Lot or batch number: Record this in your laboratory notebook. If results differ between experiments, the first question is often whether the lot changed.
- Molecular formula and molecular weight: Cross-reference the stated molecular weight against a sequence-based calculation using a peptide mass calculator. A discrepancy larger than 0.5 Da warrants follow-up with the supplier.
- Sequence: For longer or modified peptides, verify the one-letter amino acid sequence, including any post-translational mimetics, linkers, or protecting groups that should have been removed during deprotection.
Purity: The HPLC Section
Purity by reversed-phase high-performance liquid chromatography (RP-HPLC) is typically the most prominent figure on a COA, and for good reason. HPLC purity reflects the relative area percentage of the principal peak compared with all detected peaks in the chromatogram. A common misconception is that HPLC purity alone defines overall peptide quality—it does not, but it is a critical starting point.
When reviewing the HPLC section, look for the following:
- Purity percentage: Research peptides are frequently offered at ≥95% or ≥98% purity tiers. The appropriate tier depends on the sensitivity of your assay. Binding studies, enzyme kinetics, and cell-based assays often require ≥95%; NMR structural studies or isothermal titration calorimetry may demand ≥98%.
- Detection wavelength: Most COAs report UV absorbance at 214 nm, which detects the peptide bond backbone. Some suppliers also include 254 nm or 280 nm traces. If your peptide contains aromatic residues (Trp, Tyr, Phe), the 280 nm trace provides additional identity confirmation.
- Chromatographic method: A reputable supplier will state the column type, gradient, flow rate, and mobile-phase composition. This allows you to reproduce the run in-house if you need to verify a suspect batch.
- Retention time: Useful for batch-to-batch comparison. A consistent retention time across lots suggests consistent hydrophobicity and, indirectly, consistent sequence.
Note that HPLC purity is a relative measure based on UV response. Impurities with very low extinction coefficients at the detection wavelength may be underestimated. This is why HPLC data should always be read alongside mass spectrometry data.
Identity Confirmation: Mass Spectrometry
Mass spectrometry (MS) provides identity confirmation by measuring the mass-to-charge ratio of the peptide ions. Electrospray ionization (ESI-MS) is the most common technique used in peptide QC, though matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) is also encountered.
On the COA, compare the theoretical monoisotopic or average molecular weight with the observed mass. For ESI-MS, peptides are typically detected as multiply charged ions [M+nH]n+; the COA should report the calculated neutral mass after charge-state deconvolution. An agreement within 0.1–1.0 Da (depending on instrument resolution and peptide size) confirms that the correct sequence was synthesized.
Mass spectrometry does not distinguish between sequence isomers (e.g., leucine and isoleucine have identical masses), and it does not quantify impurities that happen to share the same mass as the target peptide. This is why both HPLC and MS data together are considered the minimum acceptable identity and purity package.
Water and Counterion Content
Lyophilized peptides are hygroscopic and often contain residual water, absorbed atmospheric moisture, and counterion salts (typically trifluoroacetate, acetate, or chloride from the purification and lyophilization process). These components contribute to the gross weight of the peptide powder but are not the active peptide itself.
- Karl Fischer titration (water content): This test quantifies the percentage of water by mass. Values typically range from 2% to 15% depending on peptide composition and lyophilization conditions. High water content reduces the effective peptide content per milligram of powder.
- Counterion content: TFA (trifluoroacetate) from HPLC purification can constitute 10–30% of crude peptide weight and has been shown in some published cell-biology studies to exert confounding effects at high concentrations. Suppliers who offer TFA-removal or counterion-exchange steps should document this on the COA.
- Net peptide content: Some suppliers calculate and report a corrected net peptide percentage that accounts for water and counterion contributions. When this figure is available, use it to calculate more accurate stock concentrations.
Additional Analytical Tests
Depending on the complexity of the peptide and the supplier's quality standard, a COA may include supplementary tests:
- Amino acid analysis (AAA): Acid hydrolysis followed by chromatographic quantification of individual amino acids. This provides a stoichiometric check on composition and is particularly valuable for peptides containing non-standard residues.
- Endotoxin testing: Limulus amebocyte lysate (LAL) or recombinant factor C assays detect lipopolysaccharide contamination. Relevant for peptides intended for use in cell culture or in vitro immunological assays where endotoxin would be a confound.
- Sterility testing: Relevant for aseptically handled preparations, though not standard for all research-grade products.
Storage Conditions and Retest Date
The COA should specify recommended storage conditions—commonly −20 °C or −80 °C, protected from light, under inert atmosphere for oxidation-sensitive sequences. A retest or expiry date indicates the period over which the supplier has validated stability under stated conditions. Storing peptides outside these conditions or past the retest date introduces chemical degradation as an uncontrolled variable.
When reconstituting lyophilized peptides, consult the COA for solubility recommendations. Some suppliers include tested solvent systems. Preparing working aliquots at the time of reconstitution and avoiding repeated freeze-thaw cycles extends practical working life and preserves the purity profile documented in the COA.
Practical COA Checklist for Researchers
- Confirm product name, catalog number, and lot number match order documentation.
- Verify molecular weight against an independent calculation.
- Check HPLC purity meets the threshold required for your assay sensitivity.
- Confirm MS observed mass matches theoretical mass within instrument tolerance.
- Note water content and counterion percentage; adjust stock concentration calculations accordingly.
- Check whether endotoxin data is required for your experimental model.
- Record storage conditions and retest date in your laboratory notebook.
- Retain the COA with raw data for experimental reproducibility and audit trail purposes.
For research use only. The information in this article is intended solely for use by qualified laboratory researchers in non-clinical, non-diagnostic research settings. Nothing in this article constitutes medical advice, therapeutic guidance, or recommendations for use in humans or animals outside of formally approved research protocols.